CSL Limited (ASX: CSL)

Company Profile: CSL Limited (ASX: CSL) is under the health care segment, and the company is engaged into development, research, manufacturing and marketing of cell culture media, human plasma fractions and pharmaceutical and diagnostic products. It is a biotherapeutics company and its segments include Seqirus, CSL Behring and CSL Intellectual Property. Other than Australia company has facilities in Switzerland, the United Kingdom and the United States. The company was incorporated in 1991 and is based in Poplar Road, Parkville, Australia.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report